MARKET WEIGHTON GROUP PRACTICE
WOLDS HOUSE, MEDFORTH STREET, MARKET WEIGHTON, YORKDM006
The percentage of patients with diabetes, on the register, with a diagnosis of nephropathy (clinical proteinuria) or micro-albuminuria who are currently treated with an ACE-I (or ARBs)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
DM 15 | 2005 | 46 | 51 | 90.2% | |
DM 15 | 2006 | 87 | 101 | 86.1% | |
DM 15 | 2007 | 83 | 90 | 92.2% | |
DM 15 | 2008 | 80 | 85 | 94.1% | |
DM 15 | 2009 | 79 | 84 | 94.0% | |
DM 15 | 2010 | 70 | 79 | 88.6% | |
DM 15 | 2011 | 66 | 76 | 86.8% | |
DM 15 | 2012 | 77 | 90 | 85.6% | |
DM 15 | 2013 | 105 | 146 | 71.9% | |
DM006 | 2014 | 121 | 155 | 78.1% | |
DM006 | 2015 | 116 | 150 | 77.3% | |
DM006 | 2016 | 108 | 145 | 74.5% | |
DM006 | 2017 | 103 | 135 | 76.3% | |
DM006 | 2018 | 99 | 129 | 76.7% | |
DM006 | 2019 | 95 | 127 | 74.8% | |
DM006 | 2020 | 92 | 127 | 72.4% | |
DM006 | 2021 | 97 | 129 | 75.2% | |
DM006 | 2022 | 85 | 115 | 73.9% | |
DM006 | 2023 | 82 | 90 | 91.1% |